Loading…
Traded Oct 5, 2026 · Filed Oct 6, 2026
The boss of Repligen sold $798K of Repligen shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$798,380
Shares × reported transaction price
69 days after results of Jul 28, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $189.50 on Oct 5, 2026, within 3% of its 52-week high, after a 5% rise over the previous 30 trading days
52-week range $102.87 (May 15, 2026) to $194.57 (Sep 29, 2026), 94% of the way up, from 251 adjusted closes. 30 trading days earlier: $181.13 on Aug 21, 2026. Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.